What is she best known for?
The fields of study she is best known for:
Her scientific interests lie mostly in Mycobacterium tuberculosis, Tuberculosis, Genetics, Genotype and Mycobacterium tuberculosis complex.
Her biological study spans a wide range of topics, including Molecular epidemiology, Locus, Population genetics and Restriction fragment length polymorphism.
Her work focuses on many connections between Restriction fragment length polymorphism and other disciplines, such as Genetic marker, that overlap with her field of interest in Polymerase chain reaction.
Her Tuberculosis research includes elements of Immunology and Virology.
The concepts of her Mycobacterium tuberculosis complex study are interwoven with issues in Clade and Mycobacterium.
Her work in Spacer Oligonucleotide Typing tackles topics such as Typing which are related to areas like Variable number tandem repeat and Tandem repeat.
Her most cited work include:
- A new evolutionary scenario for the Mycobacterium tuberculosis complex (1270 citations)
- Proposal for Standardization of Optimized Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing of Mycobacterium tuberculosis (1055 citations)
- Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology (899 citations)
What are the main themes of her work throughout her whole career to date?
Kristin Kremer spends much of her time researching Mycobacterium tuberculosis, Tuberculosis, Genotype, Genetics and Restriction fragment length polymorphism.
Kristin Kremer combines subjects such as Molecular epidemiology, Typing, Microbiology and Virology with her study of Mycobacterium tuberculosis.
Her Typing research is multidisciplinary, incorporating perspectives in Tandem repeat, Variable number tandem repeat, Minisatellite Repeat and Genotyping, Spacer Oligonucleotide Typing.
Kristin Kremer has included themes like Internal medicine, Epidemiology, Immunology and Drug resistance in her Tuberculosis study.
Her Genotype study combines topics from a wide range of disciplines, such as Genetic diversity, Mycobacterium bovis, Clade and Multiple drug resistance.
Her work deals with themes such as Genetic marker, Southern blot, Restriction enzyme and Molecular biology, which intersect with Restriction fragment length polymorphism.
She most often published in these fields:
- Mycobacterium tuberculosis (69.39%)
- Tuberculosis (50.34%)
- Genotype (37.41%)
What were the highlights of her more recent work (between 2011-2021)?
- Mycobacterium tuberculosis (69.39%)
- Tuberculosis (50.34%)
- Virology (25.17%)
In recent papers she was focusing on the following fields of study:
Her primary scientific interests are in Mycobacterium tuberculosis, Tuberculosis, Virology, Immunology and Genotype.
Kristin Kremer has researched Mycobacterium tuberculosis in several fields, including Streptomycin and Genetics, Typing, Microbiology.
The study incorporates disciplines such as Variable number tandem repeat, Restriction fragment length polymorphism and Tandem repeat in addition to Typing.
Kristin Kremer interconnects Surgery, Internal medicine, Epidemiology and Public health in the investigation of issues within Tuberculosis.
Her Virology study incorporates themes from Rickettsia helvetica and Human granulocytic anaplasmosis.
Her Mycobacterium tuberculosis complex study combines topics in areas such as Genotyping and Molecular epidemiology.
Between 2011 and 2021, her most popular works were:
- Inferring patient to patient transmission of Mycobacterium tuberculosis from whole genome sequencing data. (146 citations)
- Drug susceptibility of mycobacterium tuberculosis Beijing genotype and association with MDR TB (77 citations)
- Comparative Study of IS6110 Restriction Fragment Length Polymorphism and Variable-Number Tandem-Repeat Typing of Mycobacterium tuberculosis Isolates in the Netherlands, Based on a 5-Year Nationwide Survey (48 citations)
In her most recent research, the most cited papers focused on:
Kristin Kremer mainly focuses on Mycobacterium tuberculosis, Isoniazid, Drug resistance, Genotype and Tuberculosis.
While the research belongs to areas of Mycobacterium tuberculosis, she spends her time largely on the problem of Genetics, intersecting her research to questions surrounding Mycobacterium tuberculosis complex.
Drug resistant tuberculosis, Environmental health and Surveillance data is closely connected to Rifampicin in her research, which is encompassed under the umbrella topic of Isoniazid.
Her Drug resistance course of study focuses on Streptomycin and Immunology, Hazard ratio and Prospective cohort study.
As part of the same scientific family, Kristin Kremer usually focuses on Genotype, concentrating on Virology and intersecting with Microbiology, Extensively drug-resistant tuberculosis and Multiple drug resistance.
Her work is dedicated to discovering how Tuberculosis, Internal medicine are connected with Surgery and Public health and other disciplines.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
